Wu Jianqing, Zhao Weihong, Zhong Li, Han Zongchao, Li Baozheng, Ma Wenqin, Weigel-Kelley Kirsten A, Warrington Kenneth H, Srivastava Arun
Division of Cellular & Molecular Therapy, Department of Pediatrics, University of Florida College of Medicine, Gainesville, FL 32610, USA.
Hum Gene Ther. 2007 Feb;18(2):171-82. doi: 10.1089/hum.2006.088.
Self-complementary adeno-associated viral (scAAV) vectors bypass the requirement for viral second-strand DNA synthesis, but the packaging capacity of these vectors ( approximately 2.4 kb) is significantly smaller than that of conventional AAV vectors ( approximately 4.8 kb). We constructed human recombinant green fluorescent protein (hrGFP) expression cassettes ranging from 2.3 to 4.1 kb. Each vector was biologically active, but the transduction efficiency of vectors containing <3.3-kb genomes was significantly higher than those containing 3.5-kb genomes or larger. However, scAAV vectors containing up to approximately 3.3-kb genomes also contained single-stranded genomes, and 3.5-kb and larger genomes were packaged only as single-stranded DNA. These data suggest that the maximum packaging capacity of scAAV vectors is approximately 3.3 kb. The production of single-stranded genomes was not due to repair of the terminal resolution site (trs) in the inverted terminal repeats in the AAV genome, but rather was partly due to the use of AAV helper plasmid, known to lead to higher levels of expression of Rep proteins. The use of a helper plasmid known to lead to reduced levels of Rep proteins led to the generation of scAAV vectors that contained approximately 90% of the viral genomes in double-stranded forms. These studies demonstrate the feasibility of achieving encapsidation of larger genomes into scAAV vectors than was suggested originally, but underscore the need to exercise caution in using the appropriate helper plasmid to generate scAAV stocks capable of high-efficiency transduction that are relatively free of single-stranded DNA-containing vectors.
自我互补腺相关病毒(scAAV)载体无需病毒第二链DNA合成,但这些载体的包装容量(约2.4 kb)明显小于传统AAV载体(约4.8 kb)。我们构建了长度在2.3至4.1 kb之间的人重组绿色荧光蛋白(hrGFP)表达盒。每个载体都具有生物活性,但基因组小于3.3 kb的载体的转导效率明显高于基因组为3.5 kb或更大的载体。然而,基因组大小达约3.3 kb的scAAV载体也包含单链基因组,而3.5 kb及更大的基因组仅以单链DNA形式包装。这些数据表明,scAAV载体的最大包装容量约为3.3 kb。单链基因组的产生并非由于AAV基因组反向末端重复序列中末端分辨率位点(trs)的修复,而是部分归因于使用了已知会导致Rep蛋白表达水平更高的AAV辅助质粒。使用已知会导致Rep蛋白水平降低的辅助质粒,会产生双链形式包含约90%病毒基因组的scAAV载体。这些研究证明了将比原先认为的更大的基因组包装到scAAV载体中的可行性,但强调在使用合适的辅助质粒来产生能够高效转导且相对不含含单链DNA载体的scAAV病毒原液时需要谨慎行事。